5.6600
24-January-25 15:45:00
15 minutes delayed
Stocks
+0.2800
+5.20%
Today's range
5.0500 - 5.7200
ISIN
N/A
Source
NASDAQ
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
10 Dec 2024 06:00:00 By Nasdaq GlobeNewswire
OnKure Announces New Date for Upcoming Investor Call
25 Nov 2024 16:31:00 By Nasdaq GlobeNewswire
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
01 Nov 2024 16:30:00 By Nasdaq GlobeNewswire